- Price
- $4.01
- Day
- +1.01%
- Mkt Cap
- $225.38M
- 52W Range
- $2.97 – $7.82
- Volume
- 421.5K
- Beta
- 1.48
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Shares of Protara Therapeutics, Inc. (NASDAQ: TARA - Get Free Report) have received an average rating of "Moderate Buy" from the eight research firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and seven have assigned a buy recommendation to the company. The average
Read full article
Protara Therapeutics (TARA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read full article
MIAMI, July 20, 2026 /PRNewswire/ -- Royal Caribbean Group (NYSE: RCL) today announced the appointment of Tara Bunch, former Senior Vice President and Global Head of Operations at Airbnb, to its Board of Directors. Bunch brings more than three decades of experience scaling global technology organizations, leading complex operations, strengthening customer experience, and advancing digital transformation across highly recognized consumer brands.
Read full article